首页> 美国卫生研究院文献>BMC Proceedings >Pathway-based analysis of a genome-wide case-control association study of rheumatoid arthritis
【2h】

Pathway-based analysis of a genome-wide case-control association study of rheumatoid arthritis

机译:类风湿关节炎全基因组病例对照关联研究的基于通路的分析

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Evaluation of the association between single-nucleotide polymorphisms (SNPs) and disease outcomes is widely used to identify genetic risk factors for complex diseases. Although this analysis paradigm has made significant progress in many genetic studies, many challenges remain, such as the requirement of a large sample size to achieve adequate power. Here we use rheumatoid arthritis (RA) as an example and explore a new analysis strategy: pathway-based analysis to search for related genes and SNPs contributing to the disease.We first propose the application of measure of explained variation to quantify the predictive ability of a given SNP. We then use gene set enrichment analysis to evaluate enrichment of specific pathways, where pathways, are considered enriched if they consist of genes that are associated with the phenotype of interest above and beyond is expected by chance. The results are also compared with score tests for association analysis by adjusting for population stratification.Our study identified some significantly enriched pathways, such as "cell adhesion molecules," which are known to play a key role in RA. Our results showed that pathway-based analysis may identify other biologically interesting loci (e.g., rs1018361) related to RA: the gene (CTLA4) closest to this marker has previously been shown to be associated with RA and the gene is in the significant pathways we identified, even though the marker has not reached genome-wide significance in univariate single-marker analysis.
机译:单核苷酸多态性(SNPs)和疾病结果之间的关联性评估被广泛用于识别复杂疾病的遗传风险因素。尽管此分析范例已在许多遗传研究中取得了重大进展,但仍然存在许多挑战,例如需要大量样本才能获得足够的功效。在这里我们以类风湿关节炎(RA)为例,探索一种新的分析策略:基于途径的分析以寻找导致该疾病的相关基因和SNP。我们首先提出应用解释性变异量度来量化该疾病的预测能力。给定的SNP。然后,我们使用基因集富集分析来评估特定途径的富集,如果这些途径​​包含与感兴趣的表型相关的基因,则这些途径被认为是富集的。还将结果与得分测试进行比较,以通过调整群体分层来进行关联分析。我们的研究确定了一些明显丰富的途径,例如“细胞粘附分子”,这些途径在RA中起着关键作用。我们的结果表明,基于途径的分析可能会发现与RA相关的其他生物学有趣的位点(例如rs1018361):与该标记最接近的基因(CTLA4)先前已被证明与RA相关,并且该基因存在于我们的重要途径中即使该标记在单变量单标记分析中尚未达到全基因组意义,也可以进行鉴定。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号